Economy

The Regeneron Pharmaceuticals Inc. (REGN) Earns Neutral Rating from BTIG Research

Regentatlantic Capital LLC boosted its holdings in Regeneron Pharmaceuticals by 0.9% in the second quarter. The Polen Capital Management Llc holds 1.59 million shares with $779.11 million value, up from 1.48 million last quarter.

BTIG Research reiterated their neutral rating on shares of Regeneron Pharmaceuticals Inc. The biopharmaceutical company reported $3.13 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.73 by $0.40. About 251,773 shares traded.

Regeneron Pharmaceuticals (NASDAQ:REGN) last issued its earnings results on Thursday, August 3rd. It has outperformed by 0.70% the S&P500. Following the transaction, the chief financial officer now directly owns 10,099 shares in the company, valued at approximately $5,060,204.94. Sequoia Financial Advisors LLC now owns 712 shares of the biopharmaceutical company's stock valued at $350,000 after acquiring an additional 12 shares during the last quarter. The Loomis Sayles & Company LP holds 212,164 shares with $22.36 million value, down from 334,638 last quarter. Bard C R Inc now has $24.39 billion valuation.

In related news, Director Arthur F. Ryan sold 2,000 shares of the company's stock in a transaction that occurred on Tuesday, November 15th.

About 124 shares traded. Celldex Therapeutics, Inc. (NASDAQ:CLDX) has declined 20.62% since November 5, 2016 and is downtrending. It has underperformed by 16.70% the S&P500.

Among 29 analysts covering Regeneron Pharmaceuticals Inc. Therefore 13% are positive. Regeneron Pharmaceuticals Inc. had 92 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Boeing Co (NYSE:BA) earned "Sector Perform" rating by RBC Capital Markets on Thursday, September 3. Jefferies maintained the shares of REGN in report on Thursday, October 5 with "Hold" rating. As per Tuesday, August 11, the company rating was upgraded by Zacks. The firm has "Buy" rating given on Friday, August 21 by Vetr. Jefferies Group LLC reaffirmed a "hold" rating and issued a $471.00 price objective (up previously from $418.00) on shares of Regeneron Pharmaceuticals in a research note on Wednesday, August 9th. Credit Suisse downgraded Regeneron Pharmaceuticals Inc (NASDAQ:REGN) rating on Friday, July 14. On Wednesday, January 27 the stock rating was downgraded by Canaccord Genuity to "Hold". The firm has "Hold" rating by BMO Capital Markets given on Tuesday, July 18. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2017/11/06/regeneron-pharmaceuticals-inc-regn-stake-boosted-by-old-mutual-global-investors-uk-ltd.html.

Since May 12, 2017, it had 1 insider purchase, and 7 sales for $42.75 million activity. On Friday, May 12 the insider BROWN MICHAEL S sold $1.35 million. The institutional investor held 74,797 shares of the aerospace company at the end of 2017Q2, valued at $14.79M, down from 280,245 at the end of the previous reported quarter. Delta Asset Ltd Liability Company Tn holds 0% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) for 4 shares. GOLDSTEIN JOSEPH L sold $482,550 worth of stock. Its up 0.12, from 1.26 in 2017Q1. It also reduced Home Depot Inc.

A number of hedge funds have recently made changes to their positions in the stock. Bb&T Secs Limited Liability Co stated it has 2,496 shares. Da Davidson has 0% invested in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Regeneron Pharmaceuticals now has $43.76B valuation. During the same quarter past year, the company posted $2.82 earnings per share. Ahl Llp holds 0.03% or 3,144 shares in its portfolio. Chardan Capital cut their target price on shares of Regeneron Pharmaceuticals from $325.00 to $300.00 and set a sell rating on the stock in a research report on Monday, November 7th. Atika Ltd Liability has 1.63% invested in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) for 9,500 shares. Amer Century reported 897,336 shares. Finally, Arizona State Retirement System raised its position in shares of Regeneron Pharmaceuticals by 1.4% in the first quarter. Illinois-based Fortaleza Asset Mngmt has invested 0.57% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Lagoda Invest Mngmt Ltd Partnership invested in 54,432 shares or 10.21% of the stock.

Investors sentiment decreased to 0.86 in 2017 Q2. Ifc Holdings Inc Fl accumulated 0.02% or 480 shares. Oakmont Corp sold 205,448 shares as the company's stock rose 4.66% with the market.

COPYRIGHT VIOLATION NOTICE: "Tocqueville Asset Management L.P. Has $4.64 Million Position in Regeneron Pharmaceuticals, Inc".

Investors sentiment decreased to 1.07 in 2017 Q2. Its down 0.06, from 0.92 in 2017Q1. Insiders have sold a total of 89,468 shares of company stock valued at $42,312,448 in the last quarter. 102.75 million shares or 0.18% more from 102.56 million shares in 2017Q1 were reported. Ensemble Capital Management Llc owns 1.29 million shares or 4.54% of their USA portfolio. Sweden-based Livforsakringsbolaget Skandia Omsesidigt has invested 0.02% in Mid-America Apartment Communities Inc (NYSE:MAA). Huntington Commercial Bank invested in 34 shares or 0% of the stock. Meiji Yasuda Asset Management Ltd has 6,530 shares for 0.07% of their portfolio. Mengis Capital Mngmt holds 1,469 shares. Peloton Wealth Strategists invested in 17,952 shares. Alliancebernstein Limited Partnership holds 234,364 shares or 0.09% of its portfolio. 404,317 were accumulated by Sumitomo Mitsui Trust Hldg. About 2.11 million shares traded or 30.25% up from the average. Ubs Asset Mngmt Americas holds 545,682 shares or 0% of its portfolio. Following the sale, the director now owns 36,500 shares of the company's stock, valued at approximately $15,670,910. Hum (Put) (NYSE:HUM) was raised too. One research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and twelve have given a buy rating to the company's stock. Therefore 40% are positive. VAGELOS P ROY sold $4.26M worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) on Thursday, May 25. The rating was downgraded by Standpoint Research on Monday, November 2 to "Hold". The firm earned "Buy" rating on Monday, October 23 by Guggenheim. Argus Research maintained it with "Buy" rating and $660 target in Thursday, August 6 report. (NASDAQ:REGN) by 2.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm earned "Market Perform" rating on Wednesday, April 26 by Wells Fargo. As per Friday, October 6, the company rating was maintained by Morgan Stanley. The stock has "Outperform" rating by Raymond James on Friday, September 4.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Like this

Latest


07 November 2017
Shaun Dion Hamilton out for season for No. 2 Alabama
To this point in the season, Hamilton was second on the team with 40 tackles and third in tackles for loss with 5.5. Alabama also saw backup linebacker Mack Wilson carted off the field with a foot injury during the win over LSU .

07 November 2017
Duterte, Trump to meet in Vietnam
The Government said more than 40,000 hectares of crops had been damaged, including sugar cane, rice fields and rubber plantations. Numerous banners and posters for the Asia-Pacific Economic Co-operation summit in Danang were damaged, but were fixed by Monday.

07 November 2017
Weather for the week
It will also be a sunny and relatively warm Veteran's Day with a high near 55 and mostly sunny skies. Friday and Saturday will see the coldest temperatures, forecasters believe.

07 November 2017
Novartis files European marketing application for vehicle T tisagenlecleucel
Without giving further details, the company noted it could receive more than $100m from Novartis over the next three years. Separately, Novartis reported new long-term Cosentyx (secukinumab) data for patients with ankylosing spondylitis.

07 November 2017
Taylor Swift Threatens Lawsuit Against Critic, ACLU Issues Challenge
The ACLU is now asking that Swift's lawyers write a new letter promising that they will not pursue a lawsuit against Herning. On Monday, the ACLU sent Swift a strongly worded letter telling her to back off a critic she reportedly tried to silence.

07 November 2017
DC's 'Shazam!' Taps 'Andi Mack' Star Asher Angel To Play Billy Batson
David Sandberg, who most recently filmed Lights Out and Annabelle: Creation , will direct Shazam . Levi is starring as Batson's alter ego, the adult hero known as Captain Marvel.

06 November 2017
Joint army training exercise in Meghalaya
The joint exercise was first held in Assam in 2011 and since then both the countries have been hosting the exercise alternatively. This is the 7th edition of the joint training exercise.

06 November 2017
Serge Aurier reveals the big European clubs were afraid of his reputation
Barca signed Nelson Semedo from Benfica in July to bolster their right-back ranks and seemingly never had Aurier on their radar. Capable of brilliance going forward, Aurier has shown that a costly mistake is never too far away.

06 November 2017
Jameis Winston Exits Game With Shoulder Injury, Replaced By Ryan Fitzpatrick
After Lattimore and Bucs quarterback Jameis Winston got into it near the sideline, Evans ran over and flattened Lattimore. For their part, the Buccaneers are officially listing Winston as questionable to return with a shoulder injury.

06 November 2017
Sarah Hyland and 'Bachelorette' alum are Instagram official
Adams was rumored to be dating fellow Bachelor in Paradise star Danielle Maltby , but denied the claims to ET in September. According to EOnline.com, Sarah shared an Instagram photo with Wells and wrote, " He puts up with me ".



Recommended